Organogenesis Holdings (ORGO) Total Liabilities (2015 - 2026)
Organogenesis Holdings' (ORGO) quarterly Total Liabilities came in at $138.6 million in Q1 2026, up 39.59% year-on-year from $99.3 million in Q1 2025, and down 15.88% quarter-over-quarter from $164.8 million in Q4 2025.
Organogenesis Holdings (ORGO) Total Liabilities (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Total Liabilities history runs 12 years deep, the most recent figure standing at $138.6 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 39.59% year-over-year to $138.6 million in Q1 2026; TTM through Mar 2026 was $138.6 million, a 39.59% increase from a year earlier, with the FY2025 full-year figure at $164.8 million, up 46.41% from the prior year.
- Total Liabilities eased to $138.6 million in Q1 2026 per ORGO's latest filing, from $164.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $202.0 million in Q2 2022 and bottomed at $99.3 million in Q1 2025.
- The 5-year median for Total Liabilities is $179.7 million (2024), against an average of $163.3 million.
- Biggest YoY gain for Total Liabilities was 46.41% in 2025; the steepest drop was 44.96% in 2025.
- Year by year, Total Liabilities stood at $183.7 million in 2022, then fell by 1.27% to $181.4 million in 2023, then sank by 37.93% to $112.6 million in 2024, then soared by 46.41% to $164.8 million in 2025, then declined by 15.88% to $138.6 million in 2026.
- Per Business Quant, the three latest ORGO Total Liabilities figures stand at $138.6 million (Q1 2026), $164.8 million (Q4 2025), and $123.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn | 138.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.65 Mn |
| Dec 31, 2025 | 164.81 Mn |
| Sep 30, 2025 | 123.85 Mn |
| Jun 30, 2025 | 99.91 Mn |
| Mar 31, 2025 | 99.33 Mn |
| Dec 31, 2024 | 112.57 Mn |
| Sep 30, 2024 | 167.75 Mn |
| Jun 30, 2024 | 179.66 Mn |
| Mar 31, 2024 | 180.45 Mn |
| Dec 31, 2023 | 181.36 Mn |
| Sep 30, 2023 | 185.78 Mn |
| Jun 30, 2023 | 179.03 Mn |
| Mar 31, 2023 | 182.41 Mn |
| Dec 31, 2022 | 183.69 Mn |
| Sep 30, 2022 | 200.94 Mn |
| Jun 30, 2022 | 201.97 Mn |
| Mar 31, 2022 | 194.74 Mn |
| Dec 31, 2021 | 201.92 Mn |
| Sep 30, 2021 | 181.25 Mn |
| Jun 30, 2021 | 176.64 Mn |